Please use this identifier to cite or link to this item: http://ir.mu.ac.ke:8080/jspui/handle/123456789/9074
Title: Forequarter amputations at the Moi Teaching and Referral Hospital
Authors: Muteti, E.N.
Busakhala, N.
Vagdama, H.
Lagat, D.
Keywords: Forequarter amputation
Proximal humerus
Scapula and axillary region
Induction chemotherapy
Vascular invasion.
Issue Date: 12-Mar-2018
Publisher: East African Orthopaedic Journal
Abstract: Background: Forequarter amputation is an uncommon procedure. It is performed for high grade sarcomas of the proximal humerus, scapula and axillary region; that are not responding to induction chemotherapy or tumour progression with vascular invasion. Objective: To document the indications and results of forequarter amputations done at the Moi Teaching and Referral Hospital. Methods: Records of patients that had received a forequarter amputation in Moi Teaching and Referral Hospital between February 2012 and February 2017 were retrieved. The patient’s demographics, indication for surgery, complications and duration of survival post-operatively were noted and further analyzed. Results: A total of twelve patients were found that had a forequarter amputation done on their upper extremity. Eight were male while four were female. Ten patients (83.3%) were operated on for sarcomas including: synovial sarcoma, neurofibrosarcoma, Ewing’s sarcoma, Kaposi’s sarcoma, rhabdomyosarcoma, enchondroma, osteosarcoma and poorly differentiated sarcoma. Two patients (15.4%) were operated for squamous cell carcinoma. All the amputations were primary surgeries. Survival was 77.7% at six months and 44.4% after one year. Conclusion: The most common indication for forequarter amputation was a limb sarcoma. A one-year survival rate of 44.4% was found following forequarter amputation of a limb.
URI: http://ir.mu.ac.ke:8080/jspui/handle/123456789/9074
Appears in Collections:School of Medicine

Files in This Item:
File Description SizeFormat 
MUTETI.pdf175.61 kBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.